img

Global Sleep Disorder Therapeutics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Sleep Disorder Therapeutics Market Research Report 2024

Sleep disorders result in a lack of deep and restorative sleep.
According to MRAResearch’s new survey, global Sleep Disorder Therapeutics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sleep Disorder Therapeutics market research.
The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Sleep Disorder Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sanofi
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Somaxon Pharmaceuticals
Vanda Pharmaceuticals
Eli Lilly
GSK
Neurim Pharmaceuticals
Segment by Type
Insomnia
Excessive Sleep
Disturbed Sleep

Segment by Application


Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Sleep Disorder Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleep Disorder Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Insomnia
1.2.3 Excessive Sleep
1.2.4 Disturbed Sleep
1.3 Market by Application
1.3.1 Global Sleep Disorder Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sleep Disorder Therapeutics Market Perspective (2018-2033)
2.2 Sleep Disorder Therapeutics Growth Trends by Region
2.2.1 Global Sleep Disorder Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Sleep Disorder Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Sleep Disorder Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Sleep Disorder Therapeutics Market Dynamics
2.3.1 Sleep Disorder Therapeutics Industry Trends
2.3.2 Sleep Disorder Therapeutics Market Drivers
2.3.3 Sleep Disorder Therapeutics Market Challenges
2.3.4 Sleep Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sleep Disorder Therapeutics Players by Revenue
3.1.1 Global Top Sleep Disorder Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Sleep Disorder Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Sleep Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sleep Disorder Therapeutics Revenue
3.4 Global Sleep Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Sleep Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleep Disorder Therapeutics Revenue in 2022
3.5 Sleep Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Sleep Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Sleep Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sleep Disorder Therapeutics Breakdown Data by Type
4.1 Global Sleep Disorder Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2024-2033)
5 Sleep Disorder Therapeutics Breakdown Data by Application
5.1 Global Sleep Disorder Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Sleep Disorder Therapeutics Market Size (2018-2033)
6.2 North America Sleep Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Sleep Disorder Therapeutics Market Size by Country (2018-2023)
6.4 North America Sleep Disorder Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sleep Disorder Therapeutics Market Size (2018-2033)
7.2 Europe Sleep Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Sleep Disorder Therapeutics Market Size by Country (2018-2023)
7.4 Europe Sleep Disorder Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sleep Disorder Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Sleep Disorder Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sleep Disorder Therapeutics Market Size (2018-2033)
9.2 Latin America Sleep Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Sleep Disorder Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Sleep Disorder Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sleep Disorder Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Sleep Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Sleep Disorder Therapeutics Introduction
11.1.4 Sanofi Revenue in Sleep Disorder Therapeutics Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Sunovion Pharmaceuticals
11.2.1 Sunovion Pharmaceuticals Company Detail
11.2.2 Sunovion Pharmaceuticals Business Overview
11.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.2.4 Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2018-2023)
11.2.5 Sunovion Pharmaceuticals Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Detail
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Introduction
11.3.4 Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2018-2023)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Somaxon Pharmaceuticals
11.4.1 Somaxon Pharmaceuticals Company Detail
11.4.2 Somaxon Pharmaceuticals Business Overview
11.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.4.4 Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2018-2023)
11.4.5 Somaxon Pharmaceuticals Recent Development
11.5 Vanda Pharmaceuticals
11.5.1 Vanda Pharmaceuticals Company Detail
11.5.2 Vanda Pharmaceuticals Business Overview
11.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.5.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2018-2023)
11.5.5 Vanda Pharmaceuticals Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Sleep Disorder Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2018-2023)
11.6.5 Eli Lilly Recent Development
11.7 GSK
11.7.1 GSK Company Detail
11.7.2 GSK Business Overview
11.7.3 GSK Sleep Disorder Therapeutics Introduction
11.7.4 GSK Revenue in Sleep Disorder Therapeutics Business (2018-2023)
11.7.5 GSK Recent Development
11.8 Neurim Pharmaceuticals
11.8.1 Neurim Pharmaceuticals Company Detail
11.8.2 Neurim Pharmaceuticals Business Overview
11.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Introduction
11.8.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2018-2023)
11.8.5 Neurim Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sleep Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Insomnia
Table 3. Key Players of Excessive Sleep
Table 4. Key Players of Disturbed Sleep
Table 5. Global Sleep Disorder Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Sleep Disorder Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Sleep Disorder Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Sleep Disorder Therapeutics Market Share by Region (2018-2023)
Table 9. Global Sleep Disorder Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Sleep Disorder Therapeutics Market Share by Region (2024-2033)
Table 11. Sleep Disorder Therapeutics Market Trends
Table 12. Sleep Disorder Therapeutics Market Drivers
Table 13. Sleep Disorder Therapeutics Market Challenges
Table 14. Sleep Disorder Therapeutics Market Restraints
Table 15. Global Sleep Disorder Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Sleep Disorder Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Sleep Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapeutics as of 2022)
Table 18. Ranking of Global Top Sleep Disorder Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Sleep Disorder Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sleep Disorder Therapeutics Product Solution and Service
Table 22. Date of Enter into Sleep Disorder Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sleep Disorder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Sleep Disorder Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Sleep Disorder Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Sleep Disorder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Sleep Disorder Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Sleep Disorder Therapeutics Revenue Market Share by Application (2024-2033)
Table 32. North America Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Sleep Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Sleep Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Sleep Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Sleep Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Sleep Disorder Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Sleep Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Sleep Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Sleep Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Sanofi Company Detail
Table 48. Sanofi Business Overview
Table 49. Sanofi Sleep Disorder Therapeutics Product
Table 50. Sanofi Revenue in Sleep Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Sunovion Pharmaceuticals Company Detail
Table 53. Sunovion Pharmaceuticals Business Overview
Table 54. Sunovion Pharmaceuticals Sleep Disorder Therapeutics Product
Table 55. Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 56. Sunovion Pharmaceuticals Recent Development
Table 57. Takeda Pharmaceutical Company Detail
Table 58. Takeda Pharmaceutical Business Overview
Table 59. Takeda Pharmaceutical Sleep Disorder Therapeutics Product
Table 60. Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 61. Takeda Pharmaceutical Recent Development
Table 62. Somaxon Pharmaceuticals Company Detail
Table 63. Somaxon Pharmaceuticals Business Overview
Table 64. Somaxon Pharmaceuticals Sleep Disorder Therapeutics Product
Table 65. Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Somaxon Pharmaceuticals Recent Development
Table 67. Vanda Pharmaceuticals Company Detail
Table 68. Vanda Pharmaceuticals Business Overview
Table 69. Vanda Pharmaceuticals Sleep Disorder Therapeutics Product
Table 70. Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Vanda Pharmaceuticals Recent Development
Table 72. Eli Lilly Company Detail
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Sleep Disorder Therapeutics Product
Table 75. Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. GSK Company Detail
Table 78. GSK Business Overview
Table 79. GSK Sleep Disorder Therapeutics Product
Table 80. GSK Revenue in Sleep Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 81. GSK Recent Development
Table 82. Neurim Pharmaceuticals Company Detail
Table 83. Neurim Pharmaceuticals Business Overview
Table 84. Neurim Pharmaceuticals Sleep Disorder Therapeutics Product
Table 85. Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 86. Neurim Pharmaceuticals Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sleep Disorder Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Sleep Disorder Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Insomnia Features
Figure 4. Excessive Sleep Features
Figure 5. Disturbed Sleep Features
Figure 6. Global Sleep Disorder Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Sleep Disorder Therapeutics Market Share by Application: 2022 VS 2033
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Sleep Disorder Therapeutics Report Years Considered
Figure 12. Global Sleep Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Sleep Disorder Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Sleep Disorder Therapeutics Market Share by Region: 2022 VS 2033
Figure 15. Global Sleep Disorder Therapeutics Market Share by Players in 2022
Figure 16. Global Top Sleep Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Sleep Disorder Therapeutics Revenue in 2022
Figure 18. North America Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Sleep Disorder Therapeutics Market Share by Country (2018-2033)
Figure 20. United States Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Sleep Disorder Therapeutics Market Share by Country (2018-2033)
Figure 24. Germany Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Sleep Disorder Therapeutics Market Share by Region (2018-2033)
Figure 32. China Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Sleep Disorder Therapeutics Market Share by Country (2018-2033)
Figure 40. Mexico Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Sleep Disorder Therapeutics Market Share by Country (2018-2033)
Figure 44. Turkey Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Sleep Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Sanofi Revenue Growth Rate in Sleep Disorder Therapeutics Business (2018-2023)
Figure 47. Sunovion Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2018-2023)
Figure 48. Takeda Pharmaceutical Revenue Growth Rate in Sleep Disorder Therapeutics Business (2018-2023)
Figure 49. Somaxon Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2018-2023)
Figure 50. Vanda Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2018-2023)
Figure 51. Eli Lilly Revenue Growth Rate in Sleep Disorder Therapeutics Business (2018-2023)
Figure 52. GSK Revenue Growth Rate in Sleep Disorder Therapeutics Business (2018-2023)
Figure 53. Neurim Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapeutics Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed